Skip to main content
. Author manuscript; available in PMC: 2015 Jun 13.
Published in final edited form as: Prostate Cancer Prostatic Dis. 2004;7(2):111–117. doi: 10.1038/sj.pcan.4500712

Figure 3.

Figure 3

Composite results of zinc and citrate levels in prostate cancer, benign hyperplasia, and normal individuals. The citrate values were determined by in situ magnetic resonance spectroscopy of the prostate.14 The zinc values were determined by energy dispersive X-ray fluorescence of resected prostate tissue.13